Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside



Rating:

Share or cite this content

Citations should be made in the following way:
Marianne Riou (Strasbourg, France), Marianne Riou, Philippe Baltzinger, Michele Porzio, Tristan Degot, Sandrine Hirschi, Nicola Santelmo, Pierre-Emmanuel Falcoz, Gilbert Massard, Laurence Kessler, Romain Kessler. Impact of diabetes mellitus on survival and hospitalization after lung transplantation. Eur Respir J 2016; 48: Suppl. 60, 4645

Member's Comments

No comment yet.

Related content which might interest you: Prevalence and outcomes of diabetes in lung transplant recipients: the portuguese experience Source: Virtual Congress 2020 – Clinical management of lung transplant recipients Year: 2020 Is lung a target organ in diabetes mellitus? Source: Eur Respir J 2002; 20: Suppl. 38, 491s Year: 2002 Impact of diabetes mellitus on MDR-TB outcome Source: International Congress 2018 – Tuberculosis comorbidities Year: 2018 The impact of diabetes mellitus on healthcare costs in Taiwanese patients with respiratory failure Source: Annual Congress 2010 - Respiratory system involvement in non-pulmonary disorders Year: 2010 Increased survival in lung cancer patients with diabetes mellitus: A large cohort study Source: Annual Congress 2011 - Epidemiology of lung cancer and screening Year: 2011 Impact of diabetes mellitus on pulmonary tuberculosis clinical presentation and treatment outcomes Source: International Congress 2018 – Tuberculosis comorbidities Year: 2018 Comparison of COPD patients with and without diabetes mellitus Source: Virtual Congress 2020 – Diagnosis and management of COPD Year: 2020 Hyperglycemia and diabetes mellitus as mortality risk factors in 600 COVID-19 Romanian patients Source: Virtual Congress 2021 – COVID - 19 around the globe Year: 2021 Role of BMI in the clinical course of COPD patients with type 2 diabetes mellitus Source: International Congress 2018 – COPD and extrapulmonary comorbidities Year: 2018 Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD Source: Eur Respir J 2008; 32: 962-969 Year: 2008 Admission hyperglycaemia is associated with increased risk of diabetes mellitus following hospitalisation with community acquired pneumonia Source: Annual Congress 2012 - Scores, biomarkers and risk factors in respiratory infections Year: 2012 Pulmonary microangiopathy as a possible complication in patients with diabetes mellitus Source: Eur Respir J 2004; 24: Suppl. 48, 222s Year: 2004 Risk of development of diabetes mellitus in patients with bronchial asthma Source: Eur Respir J 2006; 28: Suppl. 50, 323s Year: 2006 Measurment of lung diffusion capacity in patients with diabetes mellitus Source: Annual Congress 2009 - Impact on respiratory function of pulmonary and extrapulmonary diseases Year: 2009 Metformin predispose acute exacerbations of COPD patients with insulin-dependent diabetes mellitus> Source: International Congress 2018 – COPD and extrapulmonary comorbidities Year: 2018 Diabetes mellitus as cause of treatment failure and relapses of pulmonary tuberculosis Source: Eur Respir J 2001; 18: Suppl. 33, 311s Year: 2001 Treatment effectiveness among patients with newly detected pulmonary tuberculosis with diabetes mellitus comorbidity Source: Eur Respir J 2004; 24: Suppl. 48, 653s Year: 2004 COPD prevalence and severity is associated to type 2 diabetes mellitus complications and lack of glycometabolic control Source: Annual Congress 2008 - COPD and comorbidities Year: 2008 Changes in lung function in a rodent model of diabetes mellitus Source: International Congress 2018 – New methods and concepts in tests of lung and respiratory muscle function Year: 2018 Impact of hyperglycaemia and comorbid diabetes mellitus on short and long-term outcome after COPD exacerbation Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement Year: 2013